Who owns ACRIVON THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Acrivon Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Acrivon Therapeutics stock

Who bought or sold ACRIVON THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
RA Capital Management 4.8M $24M 0% Dec 2023
 View chart
Perceptive Advisors 3.0M $15M 0% Dec 2023
 View chart
Citadel Advisors 1.6M $8.1M 0% Dec 2023
 View chart
Wellington Management Company 888k $4.4M 0% Dec 2023
 View chart
Marshall Wace 598k $2.9M 0% Dec 2023
 View chart
Vanguard Group 476k $2.3M 2% Dec 2023
 View chart
NEA Management Company 430k $1.3M 0% Dec 2023
 View chart
Federated Investors 226k $1.1M 0% Dec 2023
 View chart
DAFNA Capital Management 131k $646k 71% Dec 2023
 View chart
Charles Schwab Investment Management 69k $337k 1% Dec 2023
 View chart
Exchange Traded Concepts 56k $402k 323% Mar 2024
 View chart
Jacobs Levy Equity Management 46k $227k 100% Dec 2023
 View chart
Jpmorgan Chase & Co 33k $164k 25% Dec 2023
 View chart
D. E. Shaw & Co 32k $157k -32% Dec 2023
 View chart
Barclays 25k $121k 74% Dec 2023
 View chart
Bank of New York Mellon 24k $175k -2% Mar 2024
 View chart
AAFCPAs Wealth Management 11k $53k 0% Dec 2023
 View chart
Raymond James & Associates 10k $73k 100% Mar 2024
 View chart
Bank of America Corporation 10k $50k 8% Dec 2023
 View chart
Rhumbline Advisers 9.3k $46k -2% Dec 2023
 View chart
American International 4.3k $21k 0% Dec 2023
 View chart
Wells Fargo & Company 2.7k $13k 25% Dec 2023
 View chart
Royal Bank of Canada 2.5k $12k 59% Dec 2023
 View chart
New York State Common Retirement Fund 2.3k $11k -1% Dec 2023
 View chart
Citigroup 2.0k $10k 790% Dec 2023
 View chart
Legal & General Group 839.00 $4.1k 0% Dec 2023
 View chart
OTR - Nominee Name for The State Teachers Retirement Board of Ohio 800.00 $3.0k 0% Dec 2023
 View chart
Summit Investment Advisors 695.00 $3.4k 0% Dec 2023
 View chart
Amalgamated Bank 378.00 $3.0k -69% Mar 2024
 View chart
Efficient Wealth Management 88.00 $999.996800 100% Mar 2024
 View chart
Capital Advisors 48.00 $0 100% Mar 2024
 View chart
CWM 3.00 $0 100% Mar 2024
 View chart

Who sold out of Acrivon Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
UBS Group Sep 2023 102.00 $974.997600